Company intelligence / Profile preview

ZeClinics

Barcelona, Catalonia, Spainzeclinics.com ↗

Ownership: Private
Employees: ~36
Development stage: Other

Overview

ZeClinics does not develop its own therapeutics but provides preclinical safety and efficacy data using zebrafish models. Their platforms enable rapid target validation and drug candidate screening across multiple therapeutic areas. They have demonstrated the ability to streamline early-stage R&D by providing high-throughput in vivo data that correlates well with mammalian systems while reducing animal use.

Therapeutic areas: Rare DiseasesNeurologyInfectious DiseasesOphthalmologyEndocrinologyOncologyRheumatologyCardiovascular
Modalities: Small moleculeBiologicGene editing
Industry: Drug Discovery Services

Beyond the preview

Go deeper on ZeClinics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZeClinics.

Explore the full profile